The specialty drug bubble exemption may be good for pharma, but poses challenges for employers, payer and patients
Articles by Leslie Lotano-Saba
Leslie Lotano-Saba has more than 35 years of pharmacy experience, primarily in government programs with payers and PBMs. She is recognized for developing innovative and practical strategies that decrease costs and improve margin without compromising quality. Leslie established her own consulting firm, Saba and Associates, LLC, and has applied her extensive industry knowledge and expertise to assist health plans, PBMs, technology and clinical care organizations address strategic and operational issues, improving their performance.